Praveen P. Govender MB BCh

Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

72 E. Concord Street | (617) 638-4814
Praveen Govender
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Centers

Pulmonary Center

Biography

Dr. Praveen Govender is the Associate Director of the Sarcoidosis Center with training in Pulmonary Medicine, Allergy and Immunology. He has worked extensively with Dr. Jeffrey Berman in the care of patients with sarcoidosis since 2008 at The Sarcoidosis Center at Boston Medical Center. Their mission is to improve the lives of persons with sarcoidosis by providing state-of-the-art patient care coupled with innovative research aimed at understanding the pathogenesis and natural history of sarcoidosis. Dr. Govender is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG).

Education

MBBCh, Royal College of Surgeons in Ireland

BS, University of Alberta

Publications

Published on 11/1/2022

Cozier YC, Govender P, Berman JS. Obesity and Sarcoidosis Risk: An Index Under Suspicion. Chest. 2022 Nov; 162(5):954-956. PMID: 36344120.

Published on 2/22/2021

Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med. 2022 Apr; 37(4):441-458. PMID: 33611981.

Published on 10/1/2020

Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473. PMID: 31309727.

Published on 9/3/2020

Govender P, Cozier YC. Sarcoidosis in a time of pandemic. Eur Respir J. 2020 09; 56(3). PMID: 32883761.

Published on 6/30/2020

Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):184-191. PMID: 33093782.

Published on 6/30/2020

Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):234-238. PMID: 33093789.

Published on 6/30/2020

Nitzberg M, Parikh R, Govender P, Farber HW. Pulmonary hypertension secondary to takayasu's arteritis: management using a combined medical and interventional approach. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):239-241. PMID: 33093790.

Published on 4/15/2020

Cozier YC, Govender P. Sarcoidosis: An Ill-afforded Disease. Am J Respir Crit Care Med. 2020 04 15; 201(8):890-891. PMID: 31978312.

Published on 4/15/2020

Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 04 15; 201(8):e26-e51. PMID: 32293205.

Published on 9/1/2018

Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med. 2018 09; 24(5):487-494. PMID: 29979212.

View full list of 22 publications.